COVACEUSZACH, SONIA
 Distribuzione geografica
Continente #
AS - Asia 1.547
NA - Nord America 873
EU - Europa 304
SA - Sud America 301
AF - Africa 31
OC - Oceania 1
Totale 3.057
Nazione #
US - Stati Uniti d'America 828
SG - Singapore 646
CN - Cina 375
BR - Brasile 234
HK - Hong Kong 165
VN - Vietnam 156
FR - Francia 82
KR - Corea 75
NL - Olanda 61
IT - Italia 51
AR - Argentina 33
IN - India 26
GB - Regno Unito 24
JP - Giappone 21
CA - Canada 18
BD - Bangladesh 17
DE - Germania 17
FI - Finlandia 16
MX - Messico 14
ZA - Sudafrica 13
EC - Ecuador 12
TR - Turchia 12
IL - Israele 11
ID - Indonesia 10
PL - Polonia 7
VE - Venezuela 7
AT - Austria 6
CL - Cile 6
ES - Italia 6
IQ - Iraq 6
MA - Marocco 6
UA - Ucraina 6
EG - Egitto 4
PK - Pakistan 4
RU - Federazione Russa 4
SE - Svezia 4
CO - Colombia 3
EE - Estonia 3
HN - Honduras 3
KZ - Kazakistan 3
PH - Filippine 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.057
Città #
Singapore 375
Santa Clara 252
Hefei 183
Dallas 163
Hong Kong 163
Beijing 77
Seoul 75
Ho Chi Minh City 67
Lauterbourg 65
San Jose 65
Ashburn 60
Los Angeles 51
Hanoi 39
Amsterdam 27
São Paulo 22
Trieste 14
New York 12
Tokyo 11
Lappeenranta 10
Rio de Janeiro 10
Bengaluru 9
Minamishinagawa 9
Brasília 8
Orem 8
Curitiba 7
Frankfurt am Main 7
Johannesburg 7
Milan 7
Buffalo 6
Helsinki 6
Houston 6
Porto Alegre 6
Biên Hòa 5
Buenos Aires 5
Chennai 5
Haiphong 5
Quito 5
Sorocaba 5
Warsaw 5
Da Nang 4
Denver 4
Guayaquil 4
London 4
Manchester 4
Montreal 4
Nuremberg 4
Portsmouth 4
Rome 4
Santiago 4
Stockholm 4
Vienna 4
Atibaia 3
Atlanta 3
Belo Horizonte 3
Brooklyn 3
Campinas 3
Caracas 3
Dhaka 3
Fortaleza 3
Groningen 3
Istanbul 3
Manila 3
Mexico City 3
Newark 3
Piscataway 3
Quilmes 3
São Bernardo do Campo 3
Tallinn 3
Acalanes Ridge 2
Arapiraca 2
Baghdad 2
Bangkok 2
Brampton 2
Bristol 2
Bình Dương 2
Bắc Giang 2
Cairo 2
Carapicuíba 2
Cavallino 2
Chandigarh 2
Coro 2
Council Bluffs 2
Dakar 2
Dourados 2
Duque de Caxias 2
Durban 2
Düsseldorf 2
Elk Grove Village 2
Florianópolis 2
Gramado 2
Guarulhos 2
Hải Dương 2
Jakarta 2
Jeddah 2
Kyiv 2
Lahore 2
Las Vegas 2
Lấp Vò 2
Manta 2
Marseille 2
Totale 2.025
Nome #
Unveiling the Solvent Effect: DMSO Interaction with Human Nerve Growth Factor and Its Implications for Drug Discovery 206
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 95
LuxR Solos in the Plant Endophyte Kosakonia sp. Strain KO348 94
Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody 73
X-Ray Diffraction @ Elettra Synchrotron: Atomic Insight Of Your Biomedical Target. 72
Covalent immobilization of delipidated human serum albumin on poly(pyrrole-2-carboxylic) acid film for the impedimetric detection of perfluorooctanoic acid 68
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria 68
A Spectroscopic Study on the Amyloid‐β Interaction with Clicked Peptide‐Porphyrin Conjugates: a Vision Toward the Detection of Aβ Peptides in Aqueous Solution 62
Distinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg2+ 61
ATP binding to the Nerve Growth Factor: a molecular switch for neurotrophins signaling? 60
Do fats matter? Design of serum albumin bioreceptor for PFOA, from toxicological studies to biosensor applications 57
The binding of ATP to the Nerve Growth Factor: a new mechanism for neurotrophins signaling. 57
Structural and functional properties of mouse proNGF 56
Structural determinants for the molecular promiscuity of mouse proNGF 55
Molecular and structural basis of dystroglycanopathies 54
A primary dystroglycanopathy causing muscle-eye-brain disease with multicystic leukodystrophy: from cellular and biochemical analysis to a mouse model 53
Axe7A: A novel CE7 Acetylxylan esterase found in rumen bacterium Prevotella ruminicola 23. 52
In vitro receptor binding properties of a painless NGF mutein, linked to Hereditary Sensory Autonomic Neuropathy type V 50
Synchrotron Radiation as a tool for the investigation of the structural basis of primary dystroglycanopathies. 50
Endogenous modulators of neurotrophin signaling: Landscape of the transient ATP-NGF interactions 50
A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. 50
A combined evolutionary and structural approach to disclose the primary structural determinants essential for proneurotrophins biological functions 49
The NGF R100W Mutation, Associated with Hereditary Sensory Autonomic Neuropathy Type V, Specifically Affects the Binding Energetic Landscapes of NGF and of Its Precursor proNGF and p75NTR 49
LuxR Solos from Environmental Fluorescent Pseudomonads 49
The molecular basis of alpha-Dystroglycan hypoglycosylation: a crystallographic and SAXS study 48
Unveiling the binding mode of perfluorooctanoic acid to human serum albumin 47
Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis 46
Structural flexibility of human ?lpha-dystroglycan 46
Untangling the Conformational Plasticity of V66M Human proBDNF Polymorphism as a Modifier of Psychiatric Disorder Susceptibility 46
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of ?-dystroglycan 45
Structural flexibility of human alpha-dystroglycan 45
Molecular architecture of the glycogen- committed PP1/PTG holoenzyme. 44
Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity 44
The Conundrum of the High-Affinity NGF Binding Site Formation Unveiled? 40
Quorum sensing signaling studies in Pseudomonas syringae pv. actinidae 40
Insights into the Nerve Growth Factor / endogenous ligands binding mechanism. 39
Axe7A: A Novel CE7 Acetylxylan Esterase for Biomass Degradation. 39
Enzymatic systems with some potentials in biocatalysis 36
Negative Regulation of Violacein Biosynthesis in Chromobacterium violaceum 35
Conformational rigidity within plasticity promotes differential target recognition of Nerve Growth Factor 35
Purification, crystallization and preliminary X-ray analysis of the Fab fragment from MNAC13, a novel antagonistic anti- 33
The structure of the T190M mutant of murine ?-dystroglycan at high resolution: insight into the molecular basis of a primary dystroglycanopathy 33
Towards a comprehension of the structure of mouse proNGF 32
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 32
Identification of a new small Rho GTPase inhibitor effective in glioblastoma human cells 32
METHOD FOR THE HUMANIZATION OF ANTIBODIES AND HUMANIZED ANTIBODIES THEREBY OBTAINED 32
Intrinsic structural disorder of mouse proNGF 32
Intrinsic structural disorder of mouse proNGF 32
The Kiwifruit Emerging Pathogen Pseudomonas syringae pv. actinidiae Does Not Produce AHLs but Possesses Three LuxR Solos 31
Taking Pain Out of NGF: A "Painless" NGF Mutant, Linked to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic Activity 30
The molecular basis of ?-dystroglycan hypoglycosylation: a crystallographic and SAXS study 30
Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody 30
Unraveling the binding mode of the neutralizing neuroantibody aD11 to NGF 30
The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. 28
The molecular basis of alpha-dystroglycan hypoglycosylation: a crystallographic and SAXS study 28
Structural and functional properties of mouse proNGF 27
Purification, crystallization, X-ray diffraction analysis and phasing of a Fab fragment of monoclonal neuroantibody alphaD11 against nerve growth factor. 27
Novel recombinant antibodies against AD biomarkers linked to neurotrophin signalling as potential diagnostic tools 27
Functional and structural study of the dimeric inner membrane protein SbmA 27
Insights into the structure and function of mouse proNGF 26
Structural basis for the selectivity of recombinant mouse short proNGF versus NGF towards its binding partners. 26
Towards an understanding of the structure and dynamic of mouse proNGF 26
Insights into the structure of the N-terminal region of alpha-dystroglycan: a concerted crystallographic and SAXS study 25
Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: A structural insight. 25
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 24
A humanized anti-NGF antibody with analgesic properties 24
Insights into the structure of the N-terminal region of ?-dystroglycan: a concerted crystallographic and SAXS study 23
Studies on synthetic LuxR solo hybrids 23
Live cell optical super-resolution microscopy of dystroglycan mutants as a model for dystroglycanopathies in multiple cell lines 22
Structural Insights into a Novel Interkingdom Signaling Circuit by Cartography of the Ligand-Binding Sites of the Homologous QuorumSensing LuxR-Family 22
Remarkable analgesic effects of an anti-NGF monoclonal antibody with function neutralizing properties 21
Humanization of therapeutic neutralizing antibodies with analgesic effects 20
Totale 3.145
Categoria #
all - tutte 9.568
article - articoli 5.863
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 0 1 0 3 0
2024/20251.080 1 19 87 38 213 80 9 79 42 42 252 218
2025/20262.061 113 260 403 305 332 113 238 69 67 102 59 0
Totale 3.145